Social media and Essure hysteroscopic sterilization: a perfect storm

Social media and Essure hysteroscopic sterilization: a perfect storm

Volume 111, Issue 6, Pages 1105–1106


Steven R. Lindheim, M.D., M.M.M.a, Jody Lynee Madeira, J.D., Ph.D.b, Bala Bagavath, M.D.c, John C. Petrozza, M.D.d


Over the past several years, the commercial status of the Essure Coil, a permanent hysteroscopic sterilization device, has switched from assured to pressured. In July 2018, the device's manufacturer, Bayer Healthcare, announced that it would halt sales in the United States (the last country in which the device has been offered) by year's end. This decision was prompted by years of declining sales revenue and came after thousands of women filed complaints of adverse events, including device expulsion, uterine and tubal perforation, intractable pelvic pain, and bleeding necessitating hysterectomy, device-related death, unintended pregnancy and miscarriage, and a variety of other chronic symptoms (1).

Read the full text here.

Please sign in or register for FREE

Your Fertility and Sterility Dialog login information is not the same as your ASRM or EES credentials. Users must create a separate account to comment or interact on the Dialog.

Go to the profile of Steven R. Lindheim, MD, MMM
over 3 years ago

A perfect storm that will eventually find smooth sailing.